electric focusing. After raising polyclonal antibodies to the purified TRACP in rabbit, we used the antiserum to develop an ELISA. The antiserum cross-reacted with an extract of bone, but not with extracts of spleen, erythrocytes, platelets, or osteoblasts or with prostatic acid phosphatase.
With this ELISA we determined the concentration of serum TRACP in healthy men to be 197 (61-301) g/L (median and range). Serum TRACP concentrations were significantly higher in children and postmenopausal women and in patients with chronic renal failure, hyperparathyroidism, or hyperthyroidism. Estrogen replacement therapy of postmenopausal women for Here we report the purification of a TRACP from human cord plasma and the development of an ELISA based on antiserum raised to the purified isoenzyme. To study substrate specificity, we mixed the purified enzyme solution with 10 mmol/L PNPP in 0.1 moL1L citrate buffer, pH 5.7, and incubated at 37#{176}C. The reaction was stopped after 30 mm by adding an equal volume of 0.2 mol/L sodium hydroxide.
Materials and Methods Materials
The phosphate in the reaction mixture was measured with the centrifugal analyzer (31). Table 2 . Reducing agents at low concentrations activated the enzyme slightly; higher concentrations had no effect. The presence of divalent metal ions or EDTA had no effect, and molybdate inhibited the enzyme activity. Enzyme activity was lower in the presence of inorganic phosphate.
Production and Characterization of Polyclonal Antibodies
Nucleoside di-and triphosphates, a-naphthylphosphate, and pyrophosphate reacted with the enzyme such that the activity was -30% of that seen with PNPP (Table 3) . Nucleoside monophosphates and other phosphate compounds studied were poor substrates.
Characterization or Rabbit Antiserum
Against TRACP Extract from bone showed a displacement curve parallel to that of purified TRACP (Fig. 3) ; extracts (Fig. 4) , both the crude and purified enzyme preparations reacted with the antiserum and yielded a single peroxidase-stained band. There was no immune reaction with nonimmune serum (result not shown).
Immunoreactive TRACP in Human Serum
Withinand between-batch imprecisions of the ELISA were <12.5%.
The assay range was 3.5-30 pg/L. Analytical recovery of purified TRACP (10-30 pg/L) added to serum samples varied from 94% to 106%. TRACP in two serum samples stored in aliquots at -20#{176}C and -70#{176}C was stable for at least 15 weeks (data not shown).
As summarized in Table 4 , serum TRACP concentration and activity were significantly higher (P <0.001) in children than in adults. There was no significant difference in TRACP concentration or activity between men and premenopausal women. In postmenopausal women, serum TRACP concentration was 70% higher (P <0.001) and the enzyme activity was 34% higher than in premenopausal women. Hormone (estrogen) replacement therapy (HRT) for 3-6.5 months decreased serum TRACP concentration in all subjects (Fig. 5) was also significantly correlated with TRACP activity (r = 0.92, P <0.01) in the 81 healthy subjects (children, men, and pre-and postmenopausal women) (Fig. 6 ).
Discussion
Biochemical markers of bone resorption, including serum TRACP, are useful in assessing bone turnover (10). Several methods for measuring serum TRACP activity have been published (17) (18) (19) ; however, they lack specificity because of contamination from other phosphatases (33, 34). In attempts to develop specific immunoassays for the measurement of bone-specffic TRACP (9, 24), TRACPs have been purified from sev- Table 4 . Serum TRACP concentration, enzyme activity, and bone ALP activity in healthy subjects and patients with metabolic disorders. given the difficulties in obtaining osteoclastoma and hairy cell leukemia sources, and given the possible differences between TRACP from spleen and that from osteoclasts (23) . Recent evidence shows that osteoclasts express bone TRACP exclusively (38). We chose to investigate cord plasma because its yield might be higher than plasma from other sources, given the higher metabolic activity in the fetus (13) .
In this study, using (Table 5 ) and similar to that reported in studies using cDNA (38). Optimum pH, Km, and Vmax values for the enzyme were similar to that for TRACP isolated from human bone (8, 13) .
The p1 value of the enzyme was -7.0, similar to a p1 of 7.6 for rat TRACP (6), but less than the p1 >8.2 suggested (Table 5) (25) , but higher than that for hairy cell spleen (24) . The specific activity of the enzyme (17.9 kU/g) was similar to that from human bone (12.7 kU/g) (8) and from hairy cell spleen (10.4 kU/g) (24), but was much less than that for a recombinant purple acid phosphatase (190 kU/g) (41), rat bone (157 kU/g) (5), or spleen TRACP (Table 5) 
